William Richard White - 20 Jun 2023 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Chief Financial Officer
Signature
/s/ Jonathan Young, Attorney-in-Fact
Issuer symbol
AKRO
Transactions as of
20 Jun 2023
Net transactions value
-$1,020,078
Form type
4
Filing time
22 Jun 2023, 17:20:12 UTC
Previous filing
15 Jun 2023
Next filing
25 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKRO Common Stock Options Exercise $122,658 +17,500 +78% $7.01* 39,877 20 Jun 2023 Direct
transaction AKRO Common Stock Sale $1,142,735 -20,777 -52% $55.00 19,100 20 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKRO Stock Option (Right to Buy) Options Exercise $0 -17,500 -7.2% $0.000000 224,329 20 Jun 2023 Common Stock 17,500 $7.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are vested and currently exercisable..